← Back to Clinical Trials
Recruiting NCT06937554

NCT06937554 Evaluation of Functional and Nutritional Parameters in Fit Acute Leukemia Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06937554
Status Recruiting
Phase
Sponsor University of Rome Tor Vergata
Condition Acute Leukemia
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-04-10
Primary Completion 2025-09

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type OBSERVATIONAL
Interventions
observational follow up aimed at evaluating functional, physical, cognitive, and nutritional parameters

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-04-10 with a primary completion date of 2025-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This single-center observational prospective longitudinal study will assess cognitive, physical, and nutritional performance in acute leukemia patients undergoing intensive chemotherapy. Patients will provide informed consent prior to enrollment. Hematologists will oversee clinical management and approve evaluations, while physical and rehabilitation medicine specialists and a nutritionist will conduct assessments. Performance will be evaluated at admission, discharge, and three weeks (21 days) after starting chemotherapy.

Eligibility Criteria

Inclusion Criteria: * Age above 18 years * Patients affected by Acute Leukemia * Inpatients performing intensive chemotherapy * Patients with no restrictions on mobilization * Signed written informed consent in accordance with ICH/EU/GCP guidelines and national and local laws. Exclusion Criteria: * Age \<18 years * Any medical condition that the attending doctor judges as limiting to perform study related tasks

Contact & Investigator

Central Contact

Nicola Manocchio

✉ nicola.manocchio@uniroma2.it

📞 +390620908594

Frequently Asked Questions

Who can join the NCT06937554 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Acute Leukemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06937554 currently recruiting?

Yes, NCT06937554 is actively recruiting participants. Contact the research team at nicola.manocchio@uniroma2.it for enrollment information.

Where is the NCT06937554 trial being conducted?

This trial is being conducted at Rome, Italy.

Who is sponsoring the NCT06937554 clinical trial?

NCT06937554 is sponsored by University of Rome Tor Vergata. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology